Select Medical Holdings (SEM)
Days of sales outstanding (DSO)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Receivables turnover | — | — | — | — | — | |
| DSO | days | — | — | — | — | — |
December 31, 2024 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ —
= —
Based on the provided data, it appears that the days of sales outstanding (DSO) for Select Medical Holdings is not explicitly disclosed for the years ending December 31, 2020 through December 31, 2024. This lack of specific DSO figures makes it challenging to assess the efficiency of the company in collecting its accounts receivable promptly.
Without the DSO values, it is challenging to gauge the average number of days it takes for Select Medical Holdings to convert its accounts receivable into cash. A lower DSO typically indicates that the company collects payments from customers faster, improving its liquidity and cash flow position. Conversely, a higher DSO may suggest potential issues with collections and could impact the company's working capital and overall financial health.
In the absence of the DSO figures, it is recommended for stakeholders and investors to seek further information or clarification from Select Medical Holdings regarding its accounts receivable management practices and efficiency in collecting payments from customers to gain a better understanding of the company's financial performance.
Peer comparison
Dec 31, 2024